{"schema_version":"secwatch.filing_event.v1","accession":"0001071739-23-000024","form_type":"8-K","ticker":"CNC","cik":"0001071739","company_name":"CENTENE CORP","filed_at":"2023-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.777761+00:00","generated_at":"2026-06-19T22:25:04.502711+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Centene Q4 adj EPS $0.86, full-year adj EPS $5.78; revenue $144.5B (+15% YoY); guidance raised","bullets":["Q4 total revenues $35.6B (+9% YoY); full-year 2022 revenues $144.5B (+15% YoY).","Q4 GAAP diluted EPS $(0.38) includes $528M in impairments; adjusted diluted EPS $0.86.","Full-year 2022 adjusted diluted EPS $5.78 (+12% YoY); health benefits ratio 87.7%.","Completed five divestitures (Magellan Rx, Magellan Specialty Health, Ribera Salud, Centurion, HealthSmart).","2023 premium/service revenue guidance raised $2B to $131.5B-$133.5B; adj EPS guidance unchanged $6.25-$6.40."],"urls":{"canonical":"https://secwatch.observer/filing/0001071739-23-000024","json":"https://secwatch.observer/filing/0001071739-23-000024.json","markdown":"https://secwatch.observer/filing/0001071739-23-000024.md","text":"https://secwatch.observer/filing/0001071739-23-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/0001071739-23-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/cnc-20230207.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T22:25:04.502711+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2558525c4ff8ec63ff91ec462c3c46009f000ad0","claim":"CENTENE CORP reported year ended December 31, 2022 results: revenue $144,547, EPS $2.07. Guidance raised.","evidence_excerpt":"In summary, the 2022 fourth quarter and full year results were as follows: 2022 Results Q4 Full Year Total revenues (in millions) $ 35,561 $ 144,547 Premium and service revenues (in millions) $ 33,553 $ 135,479 Health benefits ratio 88.7 % 87.7 % SG&A expense ratio 9.5 % 8.6 % Adjusted SG&A expense ratio (1) 9.3 % 8.4 % GAAP diluted earnings (loss) per share $ (0.38) $ 2.07 Adjusted diluted EPS (1) $ 0.86 $ 5.78","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/0001071739-23-000024-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ended December 31, 2022"},{"label":"Revenue","value":"$144,547"},{"label":"EPS","value":"$2.07"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"fb811502d589fcfd4cfc3beebad49eaf38e38aa7","claim":"CENTENE CORP reported fourth quarter ended December 31, 2022 results: revenue $35,561, EPS $ (0.38). Guidance raised.","evidence_excerpt":"In summary, the 2022 fourth quarter and full year results were as follows: 2022 Results Q4 Full Year Total revenues (in millions) $ 35,561 $ 144,547 Premium and service revenues (in millions) $ 33,553 $ 135,479 Health benefits ratio 88.7 % 87.7 % SG&A expense ratio 9.5 % 8.6 % Adjusted SG&A expense ratio (1) 9.3 % 8.4 % GAAP diluted earnings (loss) per share $ (0.38) $ 2.07 Adjusted diluted EPS (1) $ 0.86 $ 5.78","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/0001071739-23-000024-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$35,561"},{"label":"EPS","value":"$ (0.38)"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}